U.S. Markets closed

Harbor Diversified, Inc. (HRBR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.025-0.001 (-2.344%)
At close: 2:19PM EDT
People also watch

Harbor Diversified, Inc.

9191 Towne Centre Drive
Suite 409
San Diego, CA 92122
United States

IndustryDrug Manufacturers - Other
Full Time Employees8

Key Executives

Mr. Robert W. WeberCFO, Chief Accounting Officer, VP of Operations, Controller and Sec.242.6kN/A66
Dr. Christopher L. Reading Ph.D.Chief Scientific Officer188.81kN/A69
Mr. Scott A. RiegerVP of Corp. CommunicationsN/AN/AN/A
Mr. Robert L. MarsellaSr. VP of Bus. Devel. and MarketingN/AN/A64
Amounts are as of December 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Harbor Diversified, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of products for the treatment of diseases related to aging. The company primarily focuses on the development of a series of steroid hormone analogs that are derived from the human adrenal metabolome. Its development-stage product candidates that have completed Phase I/IIa clinical trials include Apoptone (HE3235) for use in patients with late-stage prostate cancer; and Triolex (HE3286) used in obese type 2 diabetes mellitus patients. The company was formerly known as Harbor BioSciences, Inc. and changed its name to Harbor Diversified, Inc. in February 2012. Harbor Diversified, Inc. was founded in 1992 and is headquartered in San Diego, California.

Corporate Governance

Harbor Diversified, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.